Vanguard Fiduciary Trust
DWTX

Vanguard Fiduciary Trust’s Dogwood Therapeutics DWTX Stock Holding History

Vanguard Fiduciary Trust’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Hold
62,736
– – ﹤0.01% 3738
2026
Q1 		$132K Buy
+62,736
New +$185K ﹤0.01% 3646

Other funds holding DWTX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust's DWTX Position: Q2 2026 in Review

Vanguard Fiduciary Trust held its Dogwood Therapeutics (DWTX) position steady in Q2 2026 at 62,736 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #3738.

Vanguard Fiduciary Trust first reported a position in DWTX in Q1 2026 and has held it in 2 quarters since. The position peaked at $132K in Q1 2026. 16 funds tracked by Wall St. Rank hold DWTX as of Q2 2026.

  • Vanguard Fiduciary Trust held 62,736 shares of Dogwood Therapeutics worth $101K as of Q2 2026.
  • Vanguard Fiduciary Trust left its Dogwood Therapeutics share count unchanged in Q2 2026.
  • Dogwood Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3738 holding.
  • Vanguard Fiduciary Trust first reported a position in Dogwood Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Dogwood Therapeutics position peaked at $132K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.